#1 Clinical Trials Search in Europe

Dried Ferrous Sulfate

This article discusses the use of Dried Ferrous Sulfate in clinical trials for treating chemotherapy-induced anemia, particularly in colorectal cancer patients undergoing FOLFOX chemotherapy. We’ll explore its potential benefits, compare it to intravenous iron infusion, and examine its impact on various health parameters and quality of life for patients.

Table of Contents

What is Dried Ferrous Sulfate?

Dried Ferrous Sulfate is an oral iron supplement used to treat iron deficiency and anemia[1]. It is a form of iron that can be taken by mouth to help increase iron levels in the body. Iron is an essential component of hemoglobin, the protein in red blood cells that carries oxygen throughout the body. When iron levels are low, it can lead to a condition called anemia, where the body doesn’t have enough healthy red blood cells to transport oxygen effectively.

Uses of Dried Ferrous Sulfate

In the context of the clinical trial described, Dried Ferrous Sulfate is being studied for its effectiveness in treating chemotherapy-induced anemia in patients with colon cancer[1]. Chemotherapy-induced anemia is a common side effect of cancer treatment, particularly in patients receiving a chemotherapy regimen called FOLFOX (a combination of drugs including 5-FU and oxaliplatin).

Specifically, the study aims to evaluate the effect of oral iron supplements (Dried Ferrous Sulfate) compared to intravenous iron infusions in treating anemia caused by chemotherapy. This type of anemia occurs in about 30% of patients undergoing FOLFOX chemotherapy[1].

Comparison with Intravenous Iron

While oral iron supplements like Dried Ferrous Sulfate are widely accepted for treating chemotherapy-induced anemia, they have some drawbacks[1]:

  • Gastrointestinal discomfort: Some patients may experience stomach upset or other digestive issues when taking oral iron.
  • Long period of intake: It may take longer to see results with oral iron compared to intravenous iron.
  • Slower recovery of serum iron levels: The iron levels in the blood may take longer to normalize with oral supplements.

These factors can potentially lead to poor adherence to the treatment. In contrast, intravenous iron infusion has been reported to be effective and safe in correcting anemia, with potentially faster results[1]. The ongoing study aims to compare these two methods of iron supplementation in colon cancer patients undergoing FOLFOX chemotherapy.

Potential Side Effects

While the clinical trial information doesn’t specifically list side effects of Dried Ferrous Sulfate, oral iron supplements are known to sometimes cause gastrointestinal discomfort[1]. This can include symptoms such as constipation, nausea, or stomach pain. It’s important for patients to discuss any side effects with their healthcare provider.

Ongoing Research

The clinical trial (NCT05299411) is investigating several aspects of using Dried Ferrous Sulfate for chemotherapy-induced anemia[1]:

  1. Effectiveness: The study will measure various blood parameters to assess how well the oral iron supplement works. These include:
    • Hemoglobin (Hb) levels
    • Serum iron and ferritin concentrations
    • Total iron-binding capacity
    • Other blood markers like absolute neutrophil count, platelet count, and albumin levels
  2. Inflammatory markers: The researchers will also look at markers of inflammation such as C-reactive protein, hepcidin, and interleukin-6 (IL-6).
  3. Quality of life: The study will assess how the treatment affects patients’ quality of life, specifically related to anemia, using a questionnaire called FACT-An (Version 4).
  4. Side effects: Information on chemotherapy toxicity and adverse events during treatment will be collected and analyzed.

This research aims to provide more comprehensive data on the use of oral iron supplements like Dried Ferrous Sulfate in treating chemotherapy-induced anemia, particularly in colon cancer patients undergoing FOLFOX chemotherapy[1].

Aspect Details
Study Focus Comparing Dried Ferrous Sulfate (oral) to intravenous iron for chemotherapy-induced anemia
Patient Group Colorectal cancer patients undergoing FOLFOX chemotherapy
Primary Outcome Effect on chemotherapy-induced anemia during treatment
Secondary Outcomes Serum hepcidin levels, quality of life associated with anemia
Measured Parameters Hemoglobin, iron, ferritin, blood cell counts, albumin, C-reactive protein, hepcidin, transferrin receptor, IL6
Additional Assessments Chemotoxicity, adverse events, quality of life (FACT-An questionnaire)

FAQ

  • What is Dried Ferrous Sulfate and how is it used in the clinical trial? Dried Ferrous Sulfate is an oral iron supplement used in the clinical trial as a comparator to intravenous iron infusion. It's being studied for its effectiveness in treating chemotherapy-induced anemia in colorectal cancer patients undergoing FOLFOX chemotherapy.
  • What is chemotherapy-induced anemia? Chemotherapy-induced anemia is a side effect that occurs in about 30% of patients undergoing FOLFOX chemotherapy. It's a condition where the chemotherapy treatment leads to a decrease in red blood cells, causing fatigue and other symptoms.
  • How does Dried Ferrous Sulfate compare to intravenous iron infusion? The study aims to compare the effectiveness of Dried Ferrous Sulfate (taken orally) with intravenous iron infusion in treating chemotherapy-induced anemia. While oral supplements are widely accepted, they can cause gastrointestinal discomfort and have a slower effect. Intravenous iron has shown promise in recent studies for being effective and safe.
  • What health parameters are being measured in this clinical trial? The trial is measuring various parameters including serum hemoglobin, iron, and ferritin concentrations, total iron-binding capacity, blood cell counts, albumin, C-reactive protein, hepcidin, soluble transferrin receptor, and IL6. Additionally, chemotoxicity, adverse events, and quality of life are being analyzed.
  • How is the quality of life being assessed in this study? The study is using the FACT-An (Version 4) questionnaire to assess the quality of life associated with anemia in patients. This tool helps measure the impact of anemia and its treatment on the overall well-being of patients undergoing chemotherapy.

Ongoing Clinical Trials on Dried Ferrous Sulfate

  • Study on Treating Anemia After Cesarean with Ferric Carboxymaltose or Oral Iron in Women with Moderate Iron Deficiency Anemia

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

Glossary

  • FOLFOX: A chemotherapy regimen used as first-line treatment for colorectal cancer, based on 5-FU and oxaliplatin.
  • Chemotherapy-induced anemia: A condition where chemotherapy treatment leads to a decrease in red blood cells, causing fatigue and other symptoms.
  • Ferritin: A protein in the body that stores iron and releases it when needed.
  • Hepcidin: A hormone that regulates iron absorption and distribution in the body.
  • Soluble transferrin receptor: A protein that reflects the rate of red blood cell production and iron demand in the body.
  • IL6: Interleukin 6, a protein involved in immune responses and inflammation.
  • FACT-An: Functional Assessment of Cancer Therapy – Anemia, a questionnaire used to assess quality of life in cancer patients with anemia.

References

  1. https://clinicaltrials.gov/study/NCT05299411